PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype

被引：0
|
作者：
David Beauchemin
Catherine Lacombe
Céline Van Themsche
机构：
[1] Université du Québec à Trois-Rivières,Research Group in Molecular Oncology and Endocrinology, Department of Chemistry and Biology
来源：
Molecular Cancer | / 10卷
关键词：
PAX2; estradiol; breast cancer; invasion; ERBB2; estrogen receptor alpha; luminal, MCF-7;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 12 条
  • [1] PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype
    Beauchemin, David
    Lacombe, Catherine
    Van Themsche, Celine
    MOLECULAR CANCER, 2011, 10
  • [2] Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells
    La Greca, Alejandro
    Bellora, Nicolas
    Le Dily, Francois
    Jara, Rodrigo
    Silvina Nacht, Ana
    Quilez Oliete, Javier
    Luis Villanueva, Jose
    Vidal, Enrique
    Merino, Gabriela
    Fresno, Cristobal
    Reischle, Inti Tarifa
    Vallejo, Griselda
    Vicent, Guillermo
    Fernandez, Elmer
    Beato, Miguel
    Saragueta, Patricia
    ELIFE, 2022, 11
  • [3] MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity
    Leung, Euphemia
    Kannan, Nagarajan
    Krissansen, Geoffrey W.
    Findlay, Michael P.
    Baguley, Bruce C.
    CANCER BIOLOGY & THERAPY, 2010, 9 (09) : 717 - 724
  • [4] Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells
    Sheng, Yumeng
    Cao, Manlin
    Liu, Yiwen
    He, Yiqing
    Zhang, Guoliang
    Du, Yan
    Gao, Feng
    Yang, Cuixia
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (09) : 3383 - 3391
  • [5] Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness
    Fujita, Mayumi
    Imadome, Kaori
    Somasundaram, Veena
    Kawanishi, Miki
    Karasawa, Kumiko
    Wink, David A.
    BMC CANCER, 2020, 20 (01)
  • [6] Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness
    Mayumi Fujita
    Kaori Imadome
    Veena Somasundaram
    Miki Kawanishi
    Kumiko Karasawa
    David A. Wink
    BMC Cancer, 20
  • [7] Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-alpha or the erbB2 proto-oncogene
    Connolly, JM
    Rose, DP
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (01) : 71 - 76
  • [8] The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
    Zhu, Ying
    Wu, Jianzhong
    Li, Shuchun
    Ma, Rong
    Cao, Haixia
    Ji, Minghua
    Jing, Changwen
    Tang, Jinhai
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (05) : 1225 - 1237
  • [9] CD44+/CD24-/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
    Idowu, Michael O.
    Kmieciak, Maciej
    Dumur, Catherine
    Burton, Regina S.
    Grimes, Margaret M.
    Powers, Celeste N.
    Manjili, Masoud H.
    HUMAN PATHOLOGY, 2012, 43 (03) : 364 - 373
  • [10] Low frequency ultrasound combined with baicalein can reduced the invasive capacity of breast cancer cells by down regulating the expression of MMP-2, MMP-9, and u-PA
    Xi, Qian
    Qi, Hang
    Li, Yuan
    Xi, Yan
    Zhang, Lei
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 838 - 844
12